Muhammad Zohaib Khan. FREQUENCY OF END OF TREATMENT RESPONSE IN GENOTYPE 3 CIRRHOTIC PATIENTS TAKING SOFOSBUVIR, RIBAVIRIN AND DACLATASVIR. J Popl Ther Clin Pharmacol. 2024;31(9):4104-4128. doi:10.53555/vgped651